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Abstract
Background: Age-related brain atrophy has been represented by simple 1-dimensional (1-D) measurements on
computed tomography (CT) for several decades and, more recently, with 3-dimensional (3-D) analysis, using brain
volume (BV) and cerebrospinal fluid volume (CSFV). We aimed to show that simple 1-D measurements would be
associated with 3-D values of age-related atrophy and that they would be related to post-traumatic intracranial
hemorrhage (ICH).
Methods: Patients ≥60 years with head trauma were classified with central atrophy (lateral ventricular body
width >30 mm) and/or cortical atrophy (sulcus width ≥2.5 mm). Composite atrophy was the presence of
central or cortical atrophy. BV and CSFV were computed using a Siemens Syngo workstation (VE60A).
Results: Of 177 patients, traits were age 78.3 ± 10, ICH 32.2 %, central atrophy 39.5 %, cortical atrophy 31.1 %,
composite atrophy 49.2 %, BV 1,156 ± 198 mL, and CSFV 102.5 ± 63 mL. CSFV was greater with central atrophy
(134.4 mL), than without (81.7 mL, p < 0.001). BV was lower with cortical atrophy (1,034 mL), than without
(1,211 mL; p < 0.001). BV was lower with composite atrophy (1,103 mL), than without (1,208 mL; p < 0.001).
CSFV was greater with composite atrophy (129.1 mL), than without (76.8 mL, p < 0.001). CSFV÷BV was greater
with composite atrophy (12.3 %), than without (6.7 %, p < 0.001). Age was greater with composite atrophy
(80.4 years), than without (76.3, p = 0.006). Age had an inverse correlation with BV (p < 0.001) and a direct
correlation with CSFV (p = 0.0002) and CSFV÷BV (p < 0.001). ICH was greater with composite atrophy (49.4 %),
than without (15.6 %; p < 0.001; odds ratio = 5.3). BV was lower with ICH (1,089 mL), than without (1,188 mL;
p = 0.002). CSFV÷BV was greater with ICH (11.1 %), than without (8.7 %, p = 0.02). ICH was independently
associated with central atrophy (p = 0.001) and cortical atrophy (p = 0.003).
Conclusions: Simple 1-D measurements of age-related brain atrophy are associated with 3-D values. Clinical
validity of these methods is also supported by their association with post-injury ICH. Intracranial 3-D software
is not available on many CT scanners and can be cumbersome, when available. Simple 1-D measurements,
using the study methodology, are a practical method to objectify the presence of age-related brain atrophy.
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Background
Although brain atrophy has been touted for several
decades as a risk for post-traumatic intracranial
hemorrhage (ICH), our group recently provided the
only published evidence validating this notion [1].
Specifically, we showed that 1-dimensional (1-D) esti-
mates of atrophy on brain computed tomography
(CT) have an association with the rate of ICH. For
several decades, investigators have used 1-D measure-
ments to indicate the presence of age-associated brain
atrophy. The primary representations of brain atrophy
have been lateral ventricular enlargement [2–5] and
cortical sulcal widening [2, 3, 6–12]. At least six in-
vestigations of non-demented patients have indicated
that with advancing age, the ventricular or intracranial
cerebrospinal fluid (CSF) volume increases [13–17] and
the brain volume decreases [13–15, 17, 18]. We per-
formed brain and CSF 3-dimensional (3-D) measurements
on patients described in our previous report. We hypothe-
sized that 1-D and 3-D brain CT measurements of age-
related brain atrophy would have an association. We also
hypothesized that 1-D and 3-D measurements of brain at-
rophy would be related to post-traumatic ICH.
Methods
Patient inclusion
Inclusion criteria were age ≥ 60 years, fall from standing
height or motor vehicle crash, physical evidence of head
trauma (i.e., facial fracture, skull fracture, scalp soft tis-
sue injury, facial soft tissue injury, or cervical spine in-
jury), and trauma center admission. Brain CT images
were obtained when the patient arrived at the trauma
center and stored in the regional picture archiving and
communication system (PACS) as digital imaging and
communications in medicine (DICOM) files. ICH was
determined as absent or present, according to the radi-
ology report, which was confirmed by the first author.
For patients with ICH producing major brain compres-
sion (midline shift, lateral ventricular compression, or
mesencephalic cistern compression), patients were in-
cluded, only if they had a CT without brain compression
within 6 months prior to their injury.
1-D measurements
The DICOM files were retrieved from PACS, and the
images were opened in a viewer for evaluating brain CT
images. Axial views of the brain CT were reviewed to lo-
cate and measure the maximal transverse width of the
left and right lateral ventricular bodies (i.e., the ventricu-
lar width). The brain width (i.e., the right and left trans-
verse distances from the cortical surface to the ipsilateral
ventricular margin) was measured at the axial level of
the maximal lateral ventricular body width. The intracra-
nial width was computed as the sum of the brain width
and the ventricular width. The cortical sulcus width was
assessed at the level of the maximal lateral ventricular
body width. Cortical atrophy was considered present
whenever two or more sulci each had a width ≥2.5 mm
with a decreased adjacent gyral width. Central atrophy
was considered to be present whenever the lateral ven-
tricular body width was >30 mm. Composite atrophy
was the presence of cortical atrophy, central atrophy,
or both. The principal 1-D measurements are depicted
in Fig. 1.
3-D measurements
The DICOM files, produced by a 64 slice GE LightSpeed
VCT CT system (Milwaukee, WI), were retrieved from
PACS and migrated into the Siemens syngo.via platform
(Siemens AG Healthcare Sector, Erlangen, Germany).
The DICOM files were then imported into a Siemens
Syngo multimodality workplace workstation (VE60A)
and converted to a readable format. The CSF volume
was computed by including pixels with a Hounsfield
range of 0–15 and the brain volume was calculated from
pixels with a Hounsfield range of 22–55. The Hounsfield
ranges were selected by the second author, a neuroradi-
ologist, by observing the colored areas of tissues that
would be included on the CT images, when various
Hounsfield values were used. Intracranial slices included
in the 3-D computation were those from the cranial ver-
tex to the foramen magnum (Fig. 2). An example of typ-
ical colored areas of included tissue is in Fig. 3 and an
infrequent instance with contamination is in Fig. 4. The
second author, a neuroradiologist, and the third author,
a certified CT technician, supervised the 3-D computa-
tion process.
Patient exclusion
Because patients with ICH producing major brain com-
pression would not permit accurate 1-D and 3-D mea-
surements, they were excluded, unless a CT scan
without brain compression was archived in the PACS
within the 6 months prior their injury. Patients were ex-
cluded if they met the age and injury criteria, yet the
DICOM files would not migrate into the Siemens syn-
go.via platform.
Ancillary data
Hospital admission neurologic function was a dichotomiza-
tion of the Glasgow Coma Scale score. A score of 13-15
represented normal function or minor dysfunction. A score
of 3-12 indicated major admission neurologic dysfunction.
Hospital death status, age, gender status, and 3-month out-
comes were also available. A 3-month outcome was consid-
ered to be good, if there was normal or minimally
abnormal neurologic function, and bad, if death had oc-
curred or there was severe neurologic dysfunction
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Fig. 2 3-Dimensional Measurements. The 3-dimensional measurements were obtained from the level of the skull vertex and caudal to the level
of the foramen magnum
Fig. 1 1-Dimensional Measurements. Transverse distance “A-to-B” is the maximum lateral ventricle body width; “C” is ≥ 2 cortical sulci, measuring
≥2.5 mm each; and transverse distance “D-to-E” is the intracranial width (at the level of “A-to-B”)
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(vegetative state or coma). Also available in our reliable
database was a pre-existing medical condition status for
each patient. Conditions included presence or absence of a
pre-hospital admission history for dementia, anemia, hyper-
tension, cardiac disease, anti-thrombotic agent use, diabetes
mellitus, pulmonary disease, and cerebrovascular accident.
Statistical analysis
Data were entered into a Microsoft Excel® 2010 spread-
sheet (Microsoft Corp., Redmond, WA) and imported
into SAS System for Windows, release 9.2 (SAS Institute
Inc., Cary, NC), for statistical analyses. For the continu-
ous variable cohort data, standard deviation was used to
complement the mean. Pearson correlation analysis was
performed for assessing association between two con-
tinuous variables. Periodically and for simplification of
presentation, cortical sulcus width ≥2.5 mm was
expressed as a dichotomous (dummy) variable for correl-
ation analysis. In this circumstance, a one represented
its presence and a zero its absence. Wilcoxon Rank Sum
test was used to compare continuous data between two
groups. Fischer’s exact test was used to assess the
Fig. 3 3-D Threshold Fields. a highlighting of brain parenchyma (Hounsfield range 22-55); b highlighting of CSF (Hounsfield range 0-15)
Fig. 4 3-D Threshold Fields. a highlighting of brain parenchyma (Hounsfield range 22-55); b highlighting of CSF (Hounsfield range 0–15). Brain
volume contamination in patient with extra-cranial hematoma (a: white arrow)
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relationship of two dichotomous variables. Multivariate
logistic regression analysis was performed to assess the
relationship between a dependent variable that was di-
chotomous and potential independent variables. The
level of significance was considered p < 0.05.
Results
The original cohort included 198 patients with physical
evidence of head trauma, age ≥60 years, and an ICH rate
of 36.4 % (n = 72). Because ICH created extensive com-
pression and a pre-injury CT within 6 months was un-
available, 1-D estimates of atrophy were not measured in
6 patients. The ICH rate for the 192 patients was 34.9 %
(n = 67). Of the 192 patients, we did not perform intra-
cranial 3-D estimates of atrophy in 15 (7.8 %), because
the DICOM file could not be retrieved from PACS or
they failed to migrate into the Siemens workspace. The
ICH rate for these 177 patients was 32.2 % (n = 57) and
the ICH rates for these three groups (36.4 %, 34.9 %, and
32.2 %) were similar (p = 0.7021). One hundred seventy-
seven patients comprise the subset that underwent sub-
sequent analysis. The patients’ age was 78.3 ± 10.0 years
(range, 60–99 years) and the Glasgow Coma Scale score
was 14.3 ± 2.0 (range, 3–15). Of the 57 patients with
ICH included in the analyses, 7 (12.3 %) had major brain
compression.
1-D and 3-D associations
The intracranial 1-D and 3-D outcomes are shown in
Table 1.
Age had a negative association with the brain width
and brain volume and a positive correlation with a
cortical sulcus width ≥2.5 mm, the ventricular width ÷
brain width, ventricular width ÷ intracranial width,
CSF volume, CSF volume ÷ brain volume, and CSF
volume ÷ intracranial volume; and a trend for a posi-
tive association with the ventricular width (Table 2).
Age was ≥75 years in 65.0 % (115/177) of the patients
and 60-74 years in 35.0 % (62/177). The ventricular
width was greater for age ≥75 years (31.9 ± 5.4 mm),
when compared to younger patients (29.9 ± 5.8 mm;
Wilcoxon Rank Sum test: p = 0.0217). The cortical at-
rophy rate was increased for age ≥75 years (42.6 %
[49/115]), when compared to younger patients (9.7 %
[6/62]; Fischer’s exact test: p < 0.0001). CSF volume
was greater for age ≥75 years (116 ± 60 mL), when
compared to younger patients (78 ± 59 mL; Wilcoxon
Rank Sum test: p < 0.0001). Brain volume was lower
for age ≥75 years (1086 ± 164 mL), when compared to
younger patients (1288 ± 187 mL; Wilcoxon Rank
Sum test: p < 0.0001).
The ventricular width correlations were negative with
the brain volume and positive with the CSF volume, CSF
volume ÷ brain volume, and CSF volume ÷ intracranial
volume (Table 3). The cortical sulcus width ≥2.5 mm
correlations were negative with the brain volume and
positive with the CSF volume, CSF volume ÷ brain vol-
ume, and CSF volume ÷ intracranial volume (Table 3).
The brain width correlations were negative with the CSF
volume, CSF volume ÷ brain volume, and CSF volume ÷
intracranial volume and positive with the brain volume
(Table 3). The ventricular width ÷ brain width correla-
tions were negative with the brain volume and positive
with the CSF volume, CSF volume ÷ brain volume, and
CSF volume ÷ intracranial volume (Table 3). The ven-
tricular width ÷ intracranial width correlations were
negative with the brain volume and positive with the
CSF volume, CSF volume ÷ brain volume, and CSF vol-
ume ÷ intracranial volume (Table 3).
Central atrophy (lateral ventricular body width >30 mm)
occurred in 39.5 % and was associated with a reduction in
brain volume and an increase in the CSF volume, CSF vol-
ume ÷ brain volume, and CSF volume ÷ intracranial
Table 1 Intracranial 1-dimensional and 3-dimensional outcome
Value
1-Dimensional Measurements:
Ventricular Width (mm) 31.2 ± 5.6
Cortical Sulcus Width ≥2.5 mm 31.1 %
Brain Width (mm) 90.6 ± 8.5
Ventricular Width ÷ Brain Width (%) 34.8 ± 7.4
Ventricular Width ÷ Intracranial Width (%) 25.6 ± 4.0
3-Dimensional Measurements:
CSF Volume (mL) 102.5 ± 63
Brain Volume (mL) 1156.4 ± 198
Intracranial Volume (mL) 1258.9 ± 185
CSF Volume ÷ Brain Volume (%) 9.5 ± 6.6
CSF Volume ÷ Intracranial Volume (%) 8.3 ± 5.2
Table 2 Age Correlations
r-Value P-Value
1-Dimensional Measurements:
Ventricular Width (mm) +0.13 0.0937
Cortical Sulcus Width ≥2.5 mm +0.35 <0.0001
Brain Width (mm) −0.28 0.0001
Ventricular Width ÷ Brain Width (%) +0.22 0.0041
Ventricular Width ÷ Intracranial Width (%) +0.23 0.0017
3-Dimensional Measurements:
Brain Volume (mL) −0.55 < 0.0001
CSF Volume (mL) +0.28 0.0002
CSF Volume ÷ Brain Volume (%) +0.36 < 0.0001
CSF Volume ÷ Intracranial Volume (%) +0.38 < 0.0001
Pearson correlation analysis was used for statistical assessment; Cortical Sulcus
Width ≥2.5 mm was represented as a dichotomous (dummy) variable
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volume (Table 4). Central atrophy was more frequent
with a CSF volume ≥100 mL (57.1 % [44/77]), than
with a CSF volume <100 mL (26.0 % [26/100]; Fish-
er’s exact test: p < 0.0001; odds ratio [OR= = 3.8).
Cortical atrophy (cortical sulcus width ≥2.5 mm) oc-
curred in 31.1 % and was associated with a reduction
in the brain volume and an increase in the CSF vol-
ume, CSF volume ÷ brain volume, and CSF volume ÷
intracranial volume (Table 5). Cortical atrophy was
more frequent with a brain volume <1,100 mL
(51.3 % [39/76]), than with a brain volume ≥1,100 mL
(15.8 % [16/101]; Fisher’s exact test: p < 0.0001; OR = 5.6).
Composite atrophy (ventricular or cortical atrophy) oc-
curred in 49.2 % and was associated with a reduction in
the brain volume and an increase in the CSF volume, CSF
volume ÷ brain volume, and CSF volume ÷ intracranial
volume (Table 6). Composite atrophy was more frequent
with a CSF volume ÷ brain volume ≥9.0 % (68.8 % [53/
77]), than with a CSF volume ÷ brain volume <9.0 %
(34.0 % [34/100]; Fisher’s exact test: p < 0.0001; OR = 4.3).
Composite atrophy was more frequent with a CSF
volume ÷ intracranial volume ≥10.0 % (73.7 % [42/57]),
than with a CSF volume ÷ intracranial volume <10.0 %
(37.5 % [45/120]; Fisher’s exact test: p < 0.0001; OR = 4.7).
ICH associations
ICH was associated with the ventricular width, ven-
tricular width ÷ brain width, ventricular width ÷
intracranial width, central atrophy, cortical atrophy,
and composite atrophy (Table 7). ICH was also associ-
ated with a decreased brain volume and an increased
CSF volume, CSF volume ÷ brain volume, and CSF
volume ÷ intracranial volume; however, age and gen-
der had no correlation (Table 7). The rate of ICH pro-
gressively increased with central atrophy or cortical
atrophy or both (Table 8). Multivariate logistic regres-
sion analysis demonstrated that ICH had an independ-
ent association with central atrophy (p = 0.0011) and
cortical atrophy (p = 0.0029).
Of the 177 patients, 11 (6.2 %) had major admis-
sion neurologic dysfunction and 165 (93.8 %) did
not. The ICH rate was greater in patients with
major neurologic dysfunction (63.6 % [7/11]), when
compared to those without (30.1 % [50/165];
Fischer’s exact test: p = 0.0212; OR = 4.1). The ICH
with compression was also higher for patients with
major dysfunction (27.3 % [3/11]), when compared
to those without (2.4 % [4/165]; Fischer’s exact
test: p < 0.0001; OR = 15.2). ICH was more frequent
in dying patients (75.0 % [6/8]), when compared
those surviving hospitalization (30.2 % [51/160];
Fischer’s exact test: p = 0.0078). ICH with compres-
sion was also more frequent in dying patients
(37.5 % [3/8]), when compared those surviving
hospitalization (2.4 % [4/160]; Fischer’s exact test:
p < 0.0001; RR = 1.7).
Table 3 1-Dimensional and 3-Dimensional Correlations
CSF volume Brain volume CSF volume ÷ Brain volume CSF volume ÷ Intracranial volume
Ventricular Width (mm) r = 0.46 r = -0.13 r = 0.42 r = 0.43
p < 0.0001 p = 0.0803 p < 0.0001 p < 0.0001
Cortical Sulcus Width ≥2.5 mm r = 0.45 r = -042 r = 0.50 r = 0.50
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001
Brain Width (mm) r = -0.16 r = 0.32 r = -0.20 r = -0.21
p = 0.0392 p < 0.0001 p = 0.0091 p = 0.0057
Ventricular ÷ Brain Width r = 0.45 r = -0.24 r = 0.44 r = 0.45
p < 0.0001 p = 0.0016 p < 0.0001 p < 0.0001
Ventricular ÷ Intracranial Width r = 0.46 r = -0.25 r = 0.44 r = 0.46
p < 0.0001 p = 0.0008 p < 0.0001 p < 0.0001
Pearson correlation analysis was used for statistical assessment; Cortical Sulcus Width ≥2.5 mm was represented as a dichotomous (dummy) variable
Table 4 Central Atrophy Correlations
No central atrophy Central atrophy P-Value
Number 107 (60.5 %) 70 (39.5 %)
Brain Volume (mL) 1184 ± 201 1114 ± 186 0.0196
CSF Volume (mL) 81.7 ± 46.2 134.4 ± 70.6 <0.0001
CSF Volume ÷ Brain Volume (%) 7.3 ± 5.0 12.7 ± 7.4 <0.0001
CSF Volume ÷ Intracranial Volume (%) 6.7 ± 4.0 10.9 ± 5.7 <0.0001
Wilcoxon Rank Sum test was used for statistical assessment
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Ancillary associations with 1-D and 3-D measurements
Relative to females, males were found to have increased
brain width, increased intracranial width, increased brain
volume, increased intracranial volume, and decreased
CSF volume ÷ intracranial volume (Table 9).
Patients with dementia had more cortical atrophy, re-
duced brain width, increased ventricular ÷ brain width,
increased ventricular ÷ intracranial width, increased CSF
volume, reduced brain volume, increased CSF volume ÷
brain volume, and increased CSF volume ÷ intracranial
volume (Table 10). Dementia rates were similar for pa-
tients with major admission neurologic dysfunction
(9.1 % [1/11]) and those without (20.0 % [33/166];
Fischer’s exact test: p = 0.0886). Females had a higher
rate of dementia (27.6 % [24/87]), when compared to
males (11.1 % [10/90]; Fischer’s exact test: p = 0.0054).
Patients with pre-admission anemia had a higher CSF
volume ÷ brain volume (n = 17; 14.4 %), when compared
to those without anemia (n = 160; 8.9 %; Wilcoxon Rank
Sum test: p = 0.0010). Patients with anemia also had
higher ventricular width ÷ intracranial width (27.8 %),
when compared to no anemia (25.4 %; Wilcoxon Rank
Sum test: p = 0.0140). Patients with a cardiac history had
a higher rate of cortical atrophy (39.7 % [29/73), when
compared to no cardiac history (25.0 % [26/104]; Fisher’s
exact test: p = 0.0373). As well, those with a cardiac his-
tory had a greater rate of composite atrophy (60.3 % [44/
73), when compared to patients with no cardiac history
(41.4 % [43/104]; Fisher’s exact test: p = 0.0130). Patients
receiving anti-thrombotic agents also had a higher rate
of composite atrophy (54.0 % [61/113]), when compared
to those with no use (40.6 % [26/64]; Fisher’s exact test:
p = 0.0886). A pre-admission history of diabetes mellitus,
pulmonary disease, or cerebrovascular accident did not
show any association with the 1-D or 3-D
measurements.
Of the 168 patients discharged from the hospital, 137
(81.5 %) had a good outcome at 3-months, and 31
(18.5 %) had a bad outcome. Those with a bad outcome
had a higher CSF volume ÷ brain volume (11.9 %), when
compared to patients with a good outcome (9.0 %;
Wilcoxon Rank Sum Test: p = 0.0258). The major ad-
mission neurologic dysfunction rate was greater in pa-
tients with a bad outcome (12.9 % [4/31]), when
compared to those with a good outcome (1.5 % [2/
137]; Fischer’s exact test: p = 0.0018). The rate of pre-
hospital dementia was higher in those with a bad out-
come (35.5 % [11/31]), when compared to those with
a good outcome (16.1 % [22/137]; Fischer’s exact test:
p = 0.0140). Multivariate logistic regression analysis
showed that bad outcome was independently associated
with major admission neurologic dysfunction (p = 0.0042)
and higher CSF volume ÷ brain volume (p = 0.0125). Ana-
lysis also demonstrated that bad outcome was independ-
ently associated with major admission neurologic
dysfunction (p = 0.0072) and dementia (p = 0.0123).
Discussion
Relative to our mean population values, other investiga-
tors have found comparable results for the ventricular
width [19], ventricular width ÷ intracranial width [3–5,
7], CSF volume [13, 18, 20], brain volume [13, 18, 20],
intracranial volume [16, 18, 20, 21], CSF volume ÷ brain
volume [13, 18], and CSF volume ÷ intracranial volume
[18, 21]. Threshold imperfections were minor and infre-
quent. The similarity of our values, to those published
by other researchers, suggests that our methodological
techniques were valid and appropriate.
Table 5 Cortical Atrophy Correlations
No cortical atrophy Cortical atrophy P-Value
Number 122 (68.9 %) 55 (31.1 %)
Brain Volume (mL) 1211 ± 188 1034 ± 162 <0.0001
CSF Volume (mL) 83.7 ± 49.2 144.3 ± 86.8 <0.0001
CSF Volume ÷ Brain Volume (%) 7.3 ± 4.8 14.4 ± 7.4 <0.0001
CSF Volume ÷ Intracranial Volume (%) 6.6 ± 3.9 12.2 ± 5.5 <0.0001
Wilcoxon Rank Sum test was used for statistical assessment
Table 6 Composite Atrophy Correlations
No composite atrophy Composite atrophy P-Value
Number 90 (50.8 %) 87 (49.2 %)
Brain Volume (mL) 1208 ± 194 1103 ± 188 <0.0001
CSF Volume (mL) 76.8 ± 42.7 129.1 ± 68.5 <0.0001
CSF Volume ÷ Brain Volume (%) 6.7 ± 4.2 12.3 ± 7.4 <0.0001
CSF Volume ÷ Intracranial Volume (%) 6.2 ± 3.6 10.6 ± 5.6 <0.0001
Wilcoxon Rank Sum test was used for statistical assessment
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Age associations
We demonstrated multiple correlations of age with the
1-D and 3-D intracranial measurements. We showed
that the lateral ventricular body width increased with
age, a finding also noted by Meese [19]. Of relevance,
age has also been shown to be associated with an in-
creased lateral ventricular volume [17, 22], total ven-
tricular volume [14–16], and lateral ventricular volume
÷ intracranial volume [22]. We found that the ventricu-
lar width ÷ brain width increased with progressive age, a
finding also noted by Earnest [3]. Our association of
ventricular width ÷ intracranial width with age has been
corroborated by others [5]. Other investigators have also
substantiated our finding that the brain volume de-
creases with advancing age [13, 14, 17, 18]. Similarly,
Matsumae [18] and Gur [13] have also noted an increase
in the CSF volume with progressive aging. Finally, others
have validated our finding that increasing age is associ-
ated with an increase in the CSF volume ÷ intracranial
volume [18, 21]. Our multiple correlations with age, with
corroboration by other investigators, imply that our
measurements are reliable estimates.
1-D and 3-D measurement associations
Multiple associations were noted between the relevant
1-D and 3-D measurements. In particular, logical corre-
lations existed between the brain volume and cortical
sulcus width and the brain width. Further, the CSF vol-
ume had a statistical and rational correlation with the
ventricular width. Finally, the derivative 1-D variables
correlated with their logically paired counterpart, e.g.,
the ventricular width ÷ intracranial width and CSF vol-
ume ÷ intracranial volume. These logical correlations
support the validity of the 1-D and 3-D methods utilized
to compute the dimensions. Although we found no pub-
lication in the literature that has attempted to correlate
1-D and 3-D measurements, in terms of age-related
intracranial structures, the associations were reasonably
expected.
We found that central atrophy (i.e., lateral ventricular
body width >30 mm) was associated with a reduction in
the brain volume and an increase in the CSF volume,
CSF volume ÷ brain volume, and CSF volume ÷ intra-
cranial volume. Previous investigators have concluded
that age-associated brain atrophy is manifested by an in-
creased ventricular size [5, 13–20, 22], CSF volume [13,
14, 18, 20], and CSF volume ÷ intracranial volume [18,
21] and decreased brain volume [13, 15, 17, 18, 20]. The
present study findings and existing literature indicate
that central atrophy is a valid indication of age-
associated brain atrophy.
We found that cortical atrophy (i.e., cortical sulcus
width ≥2.5 mm) was associated with a reduction in the
brain volume and an increase in the CSF volume, CSF
Table 7 Intracranial Hemorrhage Correlations
No ICH ICH P-Value
Number 120 (67.8 %) 57 (32.2 %)
1-Dimensional Measurements:
Ventricular Width (mm) 30.1 ± 5.3 33.5 ± 5.4 0.0001
Brain Width (mm) 90.6 ± 8.3 90.5 ± 9.1 0.9921
Ventricular Width ÷ Brain Width (%) 33.6 ± 6.9 37.5 ± 7.6 0.0009
Ventricular Width ÷ Intracranial Width (%) 24.9 ± 3.8 27.0 ± 4.0 0.0008
Central Atrophy 33 (27.5 %) 37 (64.9 %) <0.0001
Cortical Atrophy 24 (20.0 %) 31 (54.4 %) <0.0001
Composite Atrophy 44 (36.7 %) 43 (75.4 %) <0.0001
3-Dimensional Measurements:
CSF Volume (mL) 97.0 ± 55 114.2 ± 75 0.0875
Brain Volume (mL) 1188 ± 201 1089 ± 172 0.0017
CSF Volume ÷ Brain Volume (%) 8.7 ± 5.6 11.1 ± 8.0 0.0186
CSF Volume ÷ Intracranial Volume (%) 7.7 ± 4.5 9.6 ± 6.2 0.0254
Age (years) 77.7 ± 9.9 79.8 ± 10.0 0.1861
Female 61 (50.8 %) 26 (45.6 %) 0.5163
Wilcoxon Rank Sum test was used for statistical analysis of continuous data and Fischer’s exact test was used for dichotomous data
Table 8 Intracranial hemorrhage rates according to the
patients’ cortical and central atrophy status
Cortical atrophy Central atrophy Patient no. ICH rate
No No 90 15.6 %
Yes No 17 35.3 %
No Yes 32 37.5 %
Yes Yes 38 65.8 %
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volume ÷ brain volume, and CSF volume ÷ intracranial
volume. Multiple investigators have provided evidence
that the cortical sulcus width increases with age, indicat-
ing the presence of brain atrophy [19, 23–25]. Addition-
ally, other researchers have cited evidence that a cortical
sulcus width similar to the value used in our study,
≥2.5 mm, indicates the presence of cortical atrophy [6, 12,
19, 26]. The aforementioned indicates that a cortical sul-
cus width ≥2.5 mm is a manifestation of cortical atrophy.
We established that composite atrophy (ventricular or
cortical atrophy) was associated with a reduction in the
brain volume and an increase in the CSF volume, CSF
volume ÷ brain volume, and CSF volume ÷ intracranial
volume. Other investigators have also utilized a
combination of ventricular and sulcus dimensions as a
sign of age-related brain atrophy [5, 27–29].
The multiple associations of the 1-D measurements
with the 3-D values imply that both quantitative
methods capture similar changes of brain and CSF struc-
tures with atrophy. However, the weak correlation coeffi-
cients indicate that the two measurements provide
distinctive results. That is, 1-D measurements are not a
complete quantitative replacement for 3-D interrogation.
In particular, lateral ventricular body width principally
reflects changes in that specific structure; whereas CSF
volumes represent ventricle and extra-ventricle alter-
ations. While 1-D measurements may be more practical,
it is likely that 3-D computations might provide more
Table 9 Cranial measurements by gender status
Male Female P-value
Number 90 (50.8 %) 87 (49.2 %)
1-Dimensional Measurements:
Ventricular Width (mm) 31.9 ± 6.2 30.5 ± 4.8 0.0923
Coritcal Sulcus Width ≥2.5 mm 29.9 % 33.3 % 0.5230
Brain Width (mm) 93.1 ± 8.5 87.9 ± 7.8 <0.0001
Intracranial Width (mm) 125 ± 10 118 ± 9 <0.0001
Ventricular Width ÷ Brain Width (%) 34.6 ± 8.0 35.0 ± 6.8 0.7551
Ventricular Width ÷ Intracranial Width (%) 25.5 ± 4.3 25.7 ± 3.6 0.6562
3-Dimensional Measurements:
CSF volume (mL) 102 ± 69 104 ± 55 0.8400
Brain volume (mL) 1277 ± 179 1032 ± 125 <0.0001
Intracranial volume (mL) 1379 ± 159 1135 ± 116 <0.0001
CSF Volume ÷ Brain Volume (%) 8.5 ± 6.8 10.4 ± 6.2 0.0532
CSF Volume ÷ Intracranial Volume (%) 7.5 ± 5.3 9.2 ± 4.9 0.0331
Wilcoxon Rank Sum test was used for statistical analysis of continuous data and Fischer’s exact test was used for dichotomous data
Table 10 Cranial measurements by dementia status
No dementia Dementia P-value
143 (80.8 %) 34 (19.2 %)
1-Dimensional Measurements:
Coritcal Sulcus Width ≥2.5 mm 27.3 % 47.1 % 0.0250
Brain Width (mm) 91.5 ± 8.2 86.6 ± 8.7 0.0022
Ventricular ÷ Brain Width (%) 34.2 ± 7.0 37.3 ± 8.3 0.0262
Ventricular ÷ Intracranial Width (%) 25.3 ± 3.9 27.0 ± 4.2 0.0288
3-Dimensional Measurements:
CSF Volume (mL) 96.4 ± 62.7 128.2 ± 55.2 0.0073
Brain Volume (mL) 1185.3 ± 190 1034 ± 186 <0.0001
Intracranial Volume (mL) 1282 ± 182 1163 ± 168 0.0007
CSF Volume ÷ Brain Volume (%) 8.6 ± 6.1 13.2 ± 7.3 0.0002
CSF Volume ÷ Intracranial Volume (%) 7.6 ± 4.9 11.3 ± 5.4 0.0001
Wilcoxon Rank Sum test was used for statistical analysis of continuous data and Fischer’s exact test was used for dichotomous data
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relevant information, and thus insight, regarding certain
aspects of brain atrophy.
ICH associations
We showed that ICH was associated with 1-D (i.e., the
ventricular width, ventricular width ÷ brain width, ven-
tricular width ÷ intracranial width, central atrophy, cor-
tical atrophy, and composite atrophy) and 3-D (i.e., the
CSF volume, CSF volume ÷ brain volume, and CSF vol-
ume ÷ intracranial volume) manifestations of brain atro-
phy. Although brain atrophy has been promulgated as a
risk for ICH [30–34], there was no evidence to support
this notion, until our previous publication demonstrated
an association with 1-D estimates of brain atrophy [1].
The current study provides additional evidence that ICH
is associated with age-related brain atrophy, represented
by intracranial 3-D measurements. To our knowledge,
this is the first time that this relationship has been
demonstrated.
It is important to note that ICH had no association
with age, although the brain atrophy dimensions corre-
lated with age. Of relevance, the correlation coefficients
for age and atrophy manifestations in our study were
only moderate to weak. This is exemplified in the study
by Gur et al. which showed that advancing age had a
negative correlation with the brain volume and a positive
association with the CSF volume [13]. However, examin-
ation of their scatter plots indicated that there is sub-
stantial variance of brain and CSF volumes with each
age range. It is likely that this variance is, in part, re-
sponsible for the correlation of ICH with brain atrophy,
but not with age. That is, the existence of brain atrophy
needs to be determined according to the individual’s
brain imaging and is not an assumption based on age.
ICH progressively increased with central atrophy, cor-
tical atrophy, and both entities and it had an independ-
ent association with central atrophy and cortical
atrophy. These findings support the notion that the
presence of brain atrophy should be predicated on the
basis of both ventricular and cortical sulcus examination.
The increased rates of ICH with major admission neuro-
logic dysfunction and hospital mortality highlight the
devastating effects that ICH can have on clinical
outcomes.
Ancillary associations with 1-D and 3-D measurements
In the current study, males were found to have increased
brain width, intracranial width, brain volume, and intra-
cranial volume, and decreased CSF volume ÷ intracranial
volume, when compared to females. Other investigators
have also found that males have increased intracranial
width [6], brain volume [13, 16, 18], and intracranial vol-
ume [18], relative to females. These observations imply
that decreases in female brain volume are likely related
to cranial size.
The current investigation demonstrated that dementia
patients had more cortical atrophy, reduced brain width,
increased ventricular ÷ brain width, increased ventricu-
lar ÷ intracranial width, increased CSF volume, reduced
brain volume, increased CSF volume ÷ brain volume,
and increased CSF volume ÷ intracranial volume. Of
relevance, the literature provides evidence that others
have found that dementia is associated with increased
cortical sulcal width [8, 35, 36], increases in lateral ven-
tricular size [4, 35], increased lateral ventricular body
width-to-intracranial width ratios [4, 8], increased
ventricle-to-brain area ratio [36], and higher ventricle
volume-to-cranial volume quotients [23]. The higher
rate of dementia in females, in the current study, may
help to explain the lower intracranial volume associated
with dementia.
Patients with pre-admission anemia had a proclivity
toward brain atrophy, when compared to those without
anemia. We are uncertain as to the clinical rationale for
this observation. Similarly, patients with history of car-
diac disease or those receiving pre-admission anti-
thrombotic agents had an association with increased
brain atrophy. The grounds for these findings are also
unclear.
The 3-month neurologic dysfunction (bad) outcome
was associated with a manifestation of brain atrophy (in-
creased CSF volume ÷ brain volume), pre-admission de-
mentia, and major admission neurologic dysfunction.
These observations seem to be clinically intuitive.
1-D study measurements, a practical method
Relevant to the primary 1-D brain atrophy measure-
ments used in the current study, a representative sum-
mary of the literature is presented in Table 11. The
methodological practicality for the current study mea-
surements are considered in context of simplicity or
complexity of other methods. Many of the other
methods require multiple measurements; mandate that
multiple cuts of the brain CT must be analyzed in order
to determine the appropriate dimension to be used; or
require special software. Relative to outcome associa-
tions, an indication of clinical validation, the 1-D mea-
surements used in the current study had multiple
significant relationships. Other methods typically had
less support. Some of the other methodologies were only
validated by a subjective interpretation that atrophy was
present [2, 27], whereas others provided no evidence of
validation in the manuscript [4, 7, 11]. We believe that
the principal 1-D measurements used in the current
study are practical, objective, and supported by their
multiple associations with clinical outcomes and
conditions.
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Study limitations
Although the study was retrospective, the patients in-
cluded in the study were identified through a reliable
process, as described in our previous manuscript [1]. Pa-
tients’ ICH status was determined by the first-author
after reviewing CT scans and reports for the study pa-
tients and the credentials of the first author were de-
scribed in our previous manuscript [1]. Although the
current study excluded some patients used in the ori-
ginal study that may have created potential bias, the
similarity of the ICH rates mitigates this likelihood.
While some may find fault with our 3-D computations
using specific CSF and brain parenchymal Hounsfield
ranges, similar correlations for the CSF volume ÷ brain
volume and CSF volume ÷ intracranial volume (CSF vol-
ume + brain volume) with other outcomes suggest that
the Hounsfield ranges were valid and without CSF vol-
ume and brain volume overlap. Hemorrhage may have
confounded accurate brain volume computations, in
those with ICH. However, the major of patients did not
have ICH and, of those with ICH, the volumes were not
extensive.
Conclusions
The 3-D measurement method seems reasonable based
on 1) multiple associations of the values with clinical
conditions and outcomes; 2) similarity of results with
those in the literature; and 3) examination of the
highlighted CT images. The correlation of CT 1-D mea-
surements with 3-D values indicates that the lateral ven-
tricular body width and cortical sulcus width are reliable
indicators of age-related brain atrophy. ICH is associated
with CT 3-D indicators of brain atrophy, as well as 1-D
manifestations. Multiple clinical conditions were also as-
sociated with the 1-D measurements. Together, this indi-
cates that our 1-D criteria are valid, relative to clinical
Table 11 Complexity of 1-dimensional atrophy measurements and outcome associations
No. Methodological complexity: Outcome associations:
LVB Width:
Current investigation 177 S-C age, ICH, CSF volume
Gonzalez, 1978 [2] 100 M-C (plus frontal horn width) atrophy (subjective)
LVB ÷ IC Width:
Current investigation 177 S-C age, CSF ÷ brain volume, CSF ÷ IC volume, ICH,
dementia, anemia
Earnest, 1979 [3] 59 S-C age
Gado, 1983 [4] 24 S-C none
Steiner, 1985 [5] 148 S-C age
Sulcal Width:
Current investigation 177 S-C age, CSF volume, brain volume, CSF ÷ brain
volume, CSF ÷ IC volume, ICH, dementia, cardiac
history
Ford, 1981 [7] 59 M-C (largest sulcus) none
Pirttila, 1992 [9] 416 M-C (subjective visual widening) age, # medications, DM, HTN, CVA
Pasquier, 1996 [10] 50 M-C (13 areas; subjective widening) none
Earnest, 1979 [3] 59 M-C (sum of 4-largest sulci) age
Gyldensted, 1977 [6] 100 M-C (largest width) age
Coyle, 2006 [11] 35 S-S (mean width) none
Kochunov, 2008 [12] 31 S-S (3-D mean span) age
Gonzalez, 1978 [2] 100 M-C (sum 4 largest on highest 3 cuts) atrophy (subjective)
Kohlmeyer, 1983 [8] 150 M-C (sum of widest for frontal, temporal, parietal lobes) age
Composite Atrophy:
Current investigation 177 S-C (see LVB Width & Sulcal Width, above) brain volume, CSF volume, CSF ÷ brain volume,
CSF ÷ IC volume, ICH, cardiac history, anti-thrombotic
agent use
Fox, 1975 [27] 35 M-C (sum LVB + frontal horn width; sum 4 largest sulci,
highest 2 cuts)
atrophy (subjective)
Gonzalez, 1978 [2] 100 M-C (see above) atrophy (subjective)
LVB lateral ventricular body, S-C single cut, ICH intracranial hemorrhage, CSF cerebrospinal fluid, M-C multiple cuts, IC intracranial, DM diabetes mellitus, HTN
hypertension, CVA prior cerebrovascular accident, S-S special software
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outcomes and conditions, and 3-D measurements of
age-related brain atrophy. Results indicate that the pres-
ence of brain atrophy should be based on objective CT
1-D or 3-D measurements, and not only on the patient’s
age. Because 3-D software is not available on many CT
scanners or easy to use, brain atrophy assessment using
1-D measurement is typically more practical and avail-
able. Our radiology department is in the process of in-
corporating lateral ventricular body width >30 mm and
cortical sulcus width ≥2.5 mm assessment into the radi-
ologist’s routine brain CT examination for patients aged
≥60 years. The radiology report will include statements
regarding the presence of age-related atrophy changes,
when present, and central and cortical atrophy, when
criteria are met. We believe that such patient risk strati-
fication will assist in advancing hospital system process
improvement and will assist healthcare providers in con-
sidering relevant clinical management and prevention
strategies.
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